Today, we are proud and excited to announce a new cooperation as part of our Corporate Responsibility Program.
Evnia has joined forces with Università degli Studi di Siena, one of the oldest European Universities to create a unique Masters’ Program in Regulatory Writing!
In a time when the regulatory framework in Europe is rapidly changing (see implementation of MDR, IVDR, new Clinical Trials Regulation), this new, one-year-long, smartly designed “M.Sc. in Regulatory Writing” aims to train the future regulatory writers with the help of well-established, professional regulatory specialists, who will be delivering theoretical-practical lectures!
Here are some of the program’s Modules will include:
- Regulatory strategy for medical devices
- Clinical Evaluation Plans and Clinical Evaluation Reports
- Market authorization for medicines
- eCTD
- Development strategy for COVID-19 vaccines
- Orphan Drugs
- Medicines for pediatric populations
Through this partnership, Evnia will cover both running costs and 2 scholarships during the first year, after which our contribution will be further increased!
Supporting continuous training and #Education is in the core of Evnia’s Ethos.
We Strive for Knowledge, We Seek new Partners, We Find Solutions!
Read more:
https://lnkd.in/dQ6-Nz-h
https://lnkd.in/eCywBuiw
